title: Vaccines and recommendations for their use in inflammatory bowel disease.
abstract: The patient with inflammatory bowel disease will be predisposed to numerous infections due their immune status. It is therefore important to understand the immune and serologic status at diagnosis and to put the patient into an adapted vaccination program. This program would be applied differently according to two patient groups: the immunocompromised and the non-immunocompromised. In general, the first group would avoid the use of live-virus vaccines, and in all cases, inflammatory bowel disease treatment would take precedence over vaccine risk. It is important to individualize vaccination schedules according to the type of patient, the treatment used and the disease pattern.In addition, patient with inflammatory bowel disease should be considered for the following vaccines: varicella vaccine, human papilloma virus, influenza, pneumococcal polysaccharide vaccine and hepatitis B vaccine.
authors.affiliation: Gastroenterology Department, University Hospital of Guadalajara, 19002 Guadalajara, Spain. loladig@hotmail.com
authors.forename: María Dolores
authors.initials: MD
authors.lastname: Sánchez-Tembleque
authors.forename: Carmen
authors.initials: C
authors.lastname: Corella
authors.forename: Jose L
authors.initials: JL
authors.lastname: Pérez-Calle
mesh_terms: D001424:Bacterial Infections / Q000276:immunology / Q000382:microbiology / Q000517:prevention & control*; D001428:Bacterial Vaccines / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy* / Q000453:epidemiology / Q000276:immunology; D018579:Patient Selection; D017410:Practice Guidelines as Topic; D012307:Risk Factors; D016896:Treatment Outcome; D014611:Vaccination / Q000009:adverse effects; D014765:Viral Vaccines / Q000008:administration & dosage* / Q000009:adverse effects; D014777:Virus Diseases / Q000276:immunology / Q000517:prevention & control* / Q000821:virology
chemical_list: D001428:Bacterial Vaccines; D007166:Immunosuppressive Agents; D014765:Viral Vaccines
keywords: Crohn’s disease; Immunocompromised; Inflammatory bowel disease; Ulcerative colitis; Vaccines
references.citation: Inflamm Bowel Dis. 2009 May;15(5):649-51; author reply 651-2
references.pmid: 18831525
references.citation: MMWR Recomm Rep. 2008 Jun 6;57(RR-5):1-30; quiz CE2-4
references.pmid: 18528318
references.citation: Infect Control Hosp Epidemiol. 2007 Jun;28(6):702-7
references.pmid: 17520544
references.citation: Dig Dis. 2010;28(3):525-35
references.pmid: 20926882
references.citation: Aliment Pharmacol Ther. 2011 Mar;33(6):619-33
references.pmid: 21416659
references.citation: Am J Gastroenterol. 2006 Aug;101(8):1834-40
references.pmid: 16817843
references.citation: Infect Immun. 1998 Aug;66(8):3995-9
references.pmid: 9673295
references.citation: Ann Rheum Dis. 2008 May;67(5):713-6
references.pmid: 17965123
references.citation: Lancet. 2000 Feb 12;355(9203):561-5
references.pmid: 10683019
references.citation: MMWR Recomm Rep. 2007 Jun 22;56(RR-4):1-40
references.pmid: 17585291
references.citation: J Crohns Colitis. 2009 Jun;3(2):47-91
references.pmid: 21172250
references.citation: Inflamm Bowel Dis. 2004 Sep;10(5):677-92
references.pmid: 15472534
references.citation: Gut. 2012 Mar;61(3):385-91
references.pmid: 21757451
references.citation: Clin Gastroenterol Hepatol. 2007 Jul;5(7):851-6
references.pmid: 17544875
references.citation: Gastroenterol Hepatol (N Y). 2008 Dec;4(12):859-61
references.pmid: 21904475
references.citation: Vaccine. 2002 Jan 31;20(9-10):1340-53
references.pmid: 11818152
references.citation: Can J Gastroenterol. 2010 Feb;24(2):121-5
references.pmid: 20151071
references.citation: Am J Gastroenterol. 2010 Jan;105(1):148-54
references.pmid: 19755964
references.citation: Am J Gastroenterol. 2010 Jun;105(6):1231-8
references.pmid: 20104218
references.citation: MMWR Recomm Rep. 1993 Apr 9;42(RR-4):1-18
references.pmid: 8474421
references.citation: World J Gastroenterol. 2011 Jun 14;17(22):2708-14
references.pmid: 21734778
references.citation: Br J Haematol. 2007 Mar;136(5):699-712
references.pmid: 17338776
references.citation: Rheumatology (Oxford). 2007 Apr;46(4):608-11
references.pmid: 17114801
references.citation: J Clin Virol. 2007 Mar;38(3):189-97
references.pmid: 17258503
references.citation: MMWR Morb Mortal Wkly Rep. 2003 Jan 31;52(4):Q1-4
references.pmid: 12578326
references.citation: Inflamm Bowel Dis. 2010 Jun;16(6):925-32
references.pmid: 20480515
references.citation: Inflamm Bowel Dis. 2009 Sep;15(9):1410-6
references.pmid: 19462435
references.citation: Am J Gastroenterol. 2011 Feb;106(2):214-23; quiz 224
references.pmid: 21157441
references.citation: Dig Dis. 2012;30(4):415-9
references.pmid: 22796808
references.citation: Am J Gastroenterol. 1997 Sep;92(9):1534-7
references.pmid: 9317080
references.citation: Clin Gastroenterol Hepatol. 2007 Sep;5(9):1070-5
references.pmid: 17627901
references.citation: Am J Gastroenterol. 2004 Dec;99(12):2503-4
references.pmid: 15571606
references.citation: Arch Dis Child. 2001 Nov;85(5):351-3
references.pmid: 11668090
references.citation: Gut. 2004 Sep;53(9):1363-5
references.pmid: 15306601
references.citation: Am J Clin Pathol. 2012 Apr;137(4):516-42
references.pmid: 22431528
references.citation: Med Clin (Barc). 2009 Mar 14;132(9):331-5
references.pmid: 19268981